13 / 30
A comprehensive panel required: a Pilot study with Amplicon-seq in mCRC
n=90 (RAS mutant enriched)
NGS VHIO-card (Amplicon-seq), 60 genes
Using a routine NGS panel, 87% of cases showed at least 1
mutation
The remaining 13% are negative, most likely due to analytical
sensitivity issues